JP2002526408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002526408A5 JP2002526408A5 JP2000573360A JP2000573360A JP2002526408A5 JP 2002526408 A5 JP2002526408 A5 JP 2002526408A5 JP 2000573360 A JP2000573360 A JP 2000573360A JP 2000573360 A JP2000573360 A JP 2000573360A JP 2002526408 A5 JP2002526408 A5 JP 2002526408A5
- Authority
- JP
- Japan
- Prior art keywords
- mglur5
- antagonist
- mglur
- alkyl
- carboxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9821503.1A GB9821503D0 (en) | 1998-10-02 | 1998-10-02 | Organic compounds |
| US22081398A | 1998-12-23 | 1998-12-23 | |
| US9821503.1 | 1998-12-23 | ||
| US09/220,813 | 1998-12-23 | ||
| PCT/EP1999/007239 WO2000020001A1 (en) | 1998-10-02 | 1999-09-30 | Mglur5 antagonists for the treatment of pain and anxiety |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002526408A JP2002526408A (ja) | 2002-08-20 |
| JP2002526408A5 true JP2002526408A5 (https=) | 2006-11-24 |
Family
ID=26314451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000573360A Pending JP2002526408A (ja) | 1998-10-02 | 1999-09-30 | 疼痛および不安の処置のためのｍｇｌｕｒ５アンタゴニスト |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1117403B1 (https=) |
| JP (1) | JP2002526408A (https=) |
| KR (1) | KR20010088832A (https=) |
| CN (1) | CN1187048C (https=) |
| AT (1) | ATE255894T1 (https=) |
| AU (1) | AU765644B2 (https=) |
| BR (1) | BR9914215A (https=) |
| CA (1) | CA2345137A1 (https=) |
| DE (1) | DE69913548T2 (https=) |
| DK (1) | DK1117403T3 (https=) |
| ES (1) | ES2213389T3 (https=) |
| HU (1) | HUP0200553A3 (https=) |
| ID (1) | ID29095A (https=) |
| IL (2) | IL142047A0 (https=) |
| NO (1) | NO20011440L (https=) |
| NZ (1) | NZ510743A (https=) |
| PL (1) | PL202906B1 (https=) |
| PT (1) | PT1117403E (https=) |
| RU (1) | RU2232017C2 (https=) |
| SK (1) | SK4382001A3 (https=) |
| WO (1) | WO2000020001A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0005700D0 (en) * | 2000-03-09 | 2000-05-03 | Glaxo Group Ltd | Therapy |
| PT1345609E (pt) | 2000-12-22 | 2005-08-31 | Hoffmann La Roche | Derivados de tetra-hidro-(benzo ou tieno)-azepina-pirazina como antagonistas de mglur 1 |
| GB0128996D0 (en) | 2001-12-04 | 2002-01-23 | Novartis Ag | Organic compounds |
| SE0303418D0 (sv) * | 2003-12-17 | 2003-12-17 | Astrazeneca Ab | New use 1 |
| SE0303419D0 (sv) * | 2003-12-17 | 2003-12-17 | Astrazeneca Ab | New use 11 |
| FR2883180B1 (fr) * | 2005-03-18 | 2007-05-25 | Pierre Fabre Medicament Sa | Utilisation de l'acetyl-leucine pour la preparation d'un medicament destine au traitement de troubles de l'equilibre |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| DE102005062985A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| ES2610508T3 (es) | 2006-11-22 | 2017-04-27 | Clinical Research Associates, Llc | Métodos para tratar el síndrome de Down, el síndrome del cromosoma X frágil y el autismo |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| US8586581B2 (en) * | 2009-12-17 | 2013-11-19 | Hoffmann-La Roche Inc | Ethynyl compounds useful for treatment of CNS disorders |
| WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| US20130058915A1 (en) | 2010-03-02 | 2013-03-07 | Children's Medica Center Corporation | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| WO2011150380A1 (en) | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Methods of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
| US20120016021A1 (en) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| WO2012054724A1 (en) | 2010-10-21 | 2012-04-26 | Massachusetts Institute Of Technology | Methods of treating seizure disorders |
| AR086554A1 (es) | 2011-05-27 | 2014-01-08 | Novartis Ag | Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina |
| EP2557183A1 (de) | 2011-08-12 | 2013-02-13 | Siemens Aktiengesellschaft | Verfahren zum Betrieb einer Konti-Glühe für die Verarbeitung eines Walzguts |
| JP2015525202A (ja) | 2012-05-03 | 2015-09-03 | ノバルティス アーゲー | グレリン受容体アゴニストとしての２，７−ジアザ−スピロ［４，５］デカ−７−イル誘導体のｌ−リンゴ酸塩およびその結晶形態 |
| LT3303316T (lt) | 2015-06-03 | 2020-05-11 | F. Hoffmann-La Roche Ag | Etinilo dariniai |
| CA3066711A1 (en) | 2017-07-31 | 2019-02-07 | Novartis Ag | Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use |
| EP3459939A1 (en) | 2017-09-26 | 2019-03-27 | Pragma Therapeutics | Novel heterocyclic compounds as modulators of mglur7 |
| KR102027368B1 (ko) * | 2018-05-29 | 2019-10-01 | 서울대학교산학협력단 | 통증의 강도를 측정하는 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2056983T3 (es) * | 1988-03-21 | 1994-10-16 | Boehringer Ingelheim Pharma | Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa. |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
-
1999
- 1999-09-30 EP EP99948905A patent/EP1117403B1/en not_active Revoked
- 1999-09-30 CA CA002345137A patent/CA2345137A1/en not_active Abandoned
- 1999-09-30 ES ES99948905T patent/ES2213389T3/es not_active Expired - Lifetime
- 1999-09-30 HU HU0200553A patent/HUP0200553A3/hu unknown
- 1999-09-30 AU AU61984/99A patent/AU765644B2/en not_active Ceased
- 1999-09-30 SK SK438-2001A patent/SK4382001A3/sk unknown
- 1999-09-30 RU RU2001111868/14A patent/RU2232017C2/ru not_active IP Right Cessation
- 1999-09-30 PL PL346876A patent/PL202906B1/pl not_active IP Right Cessation
- 1999-09-30 ID IDW20010730A patent/ID29095A/id unknown
- 1999-09-30 KR KR1020017004152A patent/KR20010088832A/ko not_active Ceased
- 1999-09-30 BR BR9914215-5A patent/BR9914215A/pt not_active Application Discontinuation
- 1999-09-30 PT PT99948905T patent/PT1117403E/pt unknown
- 1999-09-30 WO PCT/EP1999/007239 patent/WO2000020001A1/en not_active Ceased
- 1999-09-30 DK DK99948905T patent/DK1117403T3/da active
- 1999-09-30 DE DE69913548T patent/DE69913548T2/de not_active Revoked
- 1999-09-30 CN CNB998117110A patent/CN1187048C/zh not_active Expired - Fee Related
- 1999-09-30 JP JP2000573360A patent/JP2002526408A/ja active Pending
- 1999-09-30 IL IL14204799A patent/IL142047A0/xx active IP Right Grant
- 1999-09-30 NZ NZ510743A patent/NZ510743A/en unknown
- 1999-09-30 AT AT99948905T patent/ATE255894T1/de active
-
2001
- 2001-03-15 IL IL142047A patent/IL142047A/en not_active IP Right Cessation
- 2001-03-21 NO NO20011440A patent/NO20011440L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002526408A5 (https=) | ||
| JP4095676B2 (ja) | 注意障害を治療するためのコリンエステラーゼ阻害剤の使用 | |
| DK2224917T3 (en) | Composition with nicotine and opipramol and its use | |
| JP2549643B2 (ja) | 神経変性症の予防及び治療における特異的ｎーメチルーｄーアスパラギン酸エステルレセプター拮抗剤としての用途 | |
| EP0542795B1 (en) | Tnf inhibitors | |
| US20240366578A1 (en) | Treatment of pain and vasoconstriction | |
| SK4382001A3 (en) | Mglur5 antagonists for the treatment of pain and anxiety | |
| JP2012131829A (ja) | そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用 | |
| CN105142623A (zh) | 用于改善认知功能的方法和组合物 | |
| KR20210139293A (ko) | 폐동맥 고혈압 및 연관 폐동맥 고혈압 치료방법 및 매일 투여 | |
| JP2000198734A (ja) | 胃運動性減弱および関連疾患の治療のための運動性増強薬 | |
| US5547979A (en) | TNF inhibition | |
| MXPA02007155A (es) | Combinaciones farmaceuticas para el tratamiento de enfermedades neurodegenerativas. | |
| EP0506545A2 (fr) | Utilisation de 4-amino-1-(2-pyridyl)pipéridines comme agonistes 5-HT3 pour le traitement et la prophylaxie des dysfonctionnements sérotoninergiques | |
| CA2684172C (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere | |
| EP3452489B1 (fr) | Nouveaux dérivés de phosphinolactones et leurs utilisations pharmaceutiques | |
| TWI342210B (en) | 2-aminobenzoyl derivatives | |
| CA2684174C (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
| FR2556216A1 (fr) | Nouveau medicament analgesique contenant du proglumide, eventuellement en association avec des medicaments analgesiques-narcotiques | |
| TW200300139A (en) | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome | |
| JP2002504134A (ja) | 疼痛を治療するためのドラフラジン類似体の使用 | |
| JP2008534526A (ja) | 湿疹の治療のためのオキサプロジンまたは密接に関連する化合物 | |
| CA2453445C (fr) | Derives de pyridin-2-yl-methylamine pour le traitement de la dependance aux opioides | |
| JP3381198B2 (ja) | １，４−ジヒドロピリジンの糖尿病における使用 | |
| BR112020005573A2 (pt) | inibidor de mpges-1 para tratamento da dor de osteoartrite |